The table below shows Co-Diagnostics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$145.95K
$145.38K
$162.91K
$50.28K
$641.14K
$2.66M
Cost of revenue
$193.77K
$26.29K
$32.11K
$21.59K
$297.40K
$212.15K
Gross profit
-$47.81K
$119.09K
$130.80K
$28.69K
$343.74K
$2.44M
R&D
$5.93M
$4.48M
$4.69M
$4.87M
$4.88M
$5.61M
CODX annual revenue (10-K history)
Co-Diagnostics, Inc. reported annual revenue of $622.49K for fiscal year 2025. That is down 84.1% from $3.92M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $7.66K (FY 2017) to $622.49K. Figures come from the company's audited annual reports as filed with the SEC.